Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Lung Cancer

  Free Subscription


10.04.2017

2 Ann Oncol
9 Ann Thorac Surg
1 Anticancer Res
1 BMC Cancer
3 BMJ
1 Cancer
1 Cancer Res
1 Cancer Sci
2 Carcinogenesis
7 Clin Lung Cancer
1 Eur J Cardiothorac Surg
2 Genes Chromosomes Cancer
3 Int J Cancer
8 Int J Oncol
1 J Cancer Res Clin Oncol
1 J Clin Oncol
5 J Natl Cancer Inst
1 Lancet Oncol
1 Mol Cancer Ther
1 Mol Carcinog
4 Oncogene
2 Oncol Rep
1 PLoS Med
2 PLoS One
1 Proc Natl Acad Sci U S A
1 Thorax


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Oncol

  1. KATAOKA Y, Ebi N, Fujimoto D, Hara S, et al
    Prior radiotherapy does not predict nivolumab response in non-small cell lung cancer: a retrospective cohort study.
    Ann Oncol. 2017 Mar 20. doi: 10.1093.
    PubMed     Text format    

  2. ZHANG Y, Zhang L, Li R, Chang DW, et al
    Genetic variations in cancer-related significantly mutated genes and lung cancer susceptibility.
    Ann Oncol. 2017 Apr 5. doi: 10.1093.
    PubMed     Text format     Abstract available


    Ann Thorac Surg

  3. YANG CJ, Chan DY, Speicher PJ, Gulack BC, et al
    Surgery Versus Optimal Medical Management for N1 Small Cell Lung Cancer.
    Ann Thorac Surg. 2017 Apr 3. pii: S0003-4975(17)30090.
    PubMed     Text format     Abstract available

  4. AFIFI RO, Mushtaq HH, Sandhu HK, Khalil K, et al
    Successful Multistaged Surgical Management of Secondary Aortoesophageal Fistula With Graft Infection.
    Ann Thorac Surg. 2016;101:e203-5.
    PubMed     Text format     Abstract available

  5. MUNOZ-LARGACHA JA, O'Hara CJ, Sloan JM, Fernando HC, et al
    Surgical Management of Pulmonary Mucosa-Associated Lymphoid Tissue Lymphoma Associated With Light-Chain Deposition Disease.
    Ann Thorac Surg. 2016;101:e207-10.
    PubMed     Text format     Abstract available

  6. WILLIAMS T, Gulack BC, Kim S, Fernandez FG, et al
    Operative Risk for Major Lung Resection Increases at Extremes of Body Mass Index.
    Ann Thorac Surg. 2017;103:296-302.
    PubMed     Text format     Abstract available

  7. HERVOCHON R, Bobbio A, Guinet C, Mansuet-Lupo A, et al
    Body Mass Index and Total Psoas Area Affect Outcomes in Patients Undergoing Pneumonectomy for Cancer.
    Ann Thorac Surg. 2017;103:287-295.
    PubMed     Text format     Abstract available

  8. SAMSON P, Crabtree T, Broderick S, Kreisel D, et al
    Quality Measures in Clinical Stage I Non-Small Cell Lung Cancer: Improved Performance Is Associated With Improved Survival.
    Ann Thorac Surg. 2017;103:303-311.
    PubMed     Text format     Abstract available

  9. KEATING J, Newton A, Venegas O, Nims S, et al
    Near-Infrared Intraoperative Molecular Imaging Can Locate Metastases to the Lung.
    Ann Thorac Surg. 2016 Oct 25. pii: S0003-4975(16)31147.
    PubMed     Text format     Abstract available

  10. OSAROGIAGBON RU, Ray MA, Faris NR, Smeltzer MP, et al
    Prognostic Value of National Comprehensive Cancer Network Lung Cancer Resection Quality Criteria.
    Ann Thorac Surg. 2017 Mar 30. pii: S0003-4975(17)30230.
    PubMed     Text format     Abstract available

  11. BENDZSAK A, Oliveira R, Goudie E, Thiffault V, et al
    Evaluation of the Mediastinum: Differentiating Between Stations 4L, 5, and 6 Using EBUS and EUS.
    Ann Thorac Surg. 2017;103:e219-e221.
    PubMed     Text format     Abstract available


    Anticancer Res

  12. TSOUKALAS N, Aravantinou-Fatorou E, Tolia M, Giaginis C, et al
    Epithelial-Mesenchymal Transition in Non Small-cell Lung Cancer.
    Anticancer Res. 2017;37:1773-1778.
    PubMed     Text format     Abstract available


    BMC Cancer

  13. LI MX, He H, Ruan ZH, Zhu YX, et al
    Central nervous system progression in advanced non-small cell lung cancer patients with EGFR mutations in response to first-line treatment with two EGFR-TKIs, gefitinib and erlotinib: a comparative study.
    BMC Cancer. 2017;17:245.
    PubMed     Text format     Abstract available


    BMJ

  14. HANCOX S, Howlett D
    A patient with head and neck swelling.
    BMJ. 2016;355:i5733.
    PubMed     Text format    

  15. BARBER Z, Kosti A, Jones C
    Breast metastases from primary lung cancer.
    BMJ. 2017;357:j1203.
    PubMed     Text format    

  16. CUDDIHY C, O'Rourke N
    New onset facial swelling.
    BMJ. 2017;356:i6474.
    PubMed     Text format    


    Cancer

  17. SABRA MM, Sherman EJ, Tuttle RM
    Tumor volume doubling time of pulmonary metastases predicts overall survival and can guide the initiation of multikinase inhibitor therapy in patients with metastatic, follicular cell-derived thyroid carcinoma.
    Cancer. 2017 Apr 3. doi: 10.1002/cncr.30690.
    PubMed     Text format     Abstract available


    Cancer Res

  18. WEN H, Chiu YF, Kuo MH, Lee KL, et al
    Expression of neuroendocrine factor VGF in lung cancer cells confers resistance to EGFR kinase inhibitors and triggers epithelial-to-mesenchymal transition.
    Cancer Res. 2017 Apr 5. pii: canres.3168.2016.
    PubMed     Text format     Abstract available


    Cancer Sci

  19. WANG R, Deng X, Yoshioka Y, Vougiouklakis T, et al
    Effects of SMYD2-mediated EML4-ALK methylation on the signaling pathway and growth in non-small cell lung cancer cells.
    Cancer Sci. 2017 Apr 1. doi: 10.1111/cas.13245.
    PubMed     Text format     Abstract available


    Carcinogenesis

  20. LIU H, Liu Z, Wang Y, Stinchcombe TE, et al
    Functional variants in DCAF4 associated with lung cancer risk in European populations.
    Carcinogenesis. 2017 Apr 5. doi: 10.1093.
    PubMed     Text format     Abstract available

  21. CHENG Y, Wang C, Zhu M, Dai J, et al
    Targeted Sequencing of Chromosome 15q25 Identified Novel Variants Associated with Risk of Lung Cancer and Smoking Behavior in Chinese.
    Carcinogenesis. 2017 Mar 27. doi: 10.1093.
    PubMed     Text format     Abstract available


    Clin Lung Cancer

  22. SPIGEL DR, Luft A, Depenbrock H, Ramlau R, et al
    An Open-Label, Randomized, Controlled Phase II Study of Paclitaxel-Carboplatin Chemotherapy With Necitumumab Versus Paclitaxel-Carboplatin Alone in First-Line Treatment of Patients With Stage IV Squamous Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2017 Mar 2. pii: S1525-7304(17)30045.
    PubMed     Text format     Abstract available

  23. VERMA V, Rwigema JM, Adeberg S, Simone CB 2nd, et al
    Enrollment of Elderly Patients With Locally Advanced Non-Small Cell Lung Cancer in Multi-institutional Trials of Proton Beam Radiation Therapy.
    Clin Lung Cancer. 2017 Mar 16. pii: S1525-7304(17)30084.
    PubMed     Text format    

  24. JUAN O, Popat S
    Ablative Therapy for Oligometastatic Non-Small Cell Lung Cancer.
    Clin Lung Cancer. 2017 Mar 14. pii: S1525-7304(17)30079.
    PubMed     Text format     Abstract available

  25. DISTASIO M, Chen Y, Rangachari D, Costa DB, et al
    Molecular Testing Turnaround Time for Non-Small Cell Lung Cancer in Routine Clinical Practice Confirms Feasibility of CAP/IASLC/AMP Guideline Recommendations: A Single-center Analysis.
    Clin Lung Cancer. 2017 Mar 14. pii: S1525-7304(17)30078.
    PubMed     Text format     Abstract available

  26. YONEDA KY, Scranton JR, Cadogan MA, Tassell V, et al
    Interstitial Lung Disease Associated With Crizotinib in Patients With Advanced Non-Small Cell Lung Cancer: Independent Review of Four PROFILE Trials.
    Clin Lung Cancer. 2017 Mar 14. pii: S1525-7304(17)30081.
    PubMed     Text format     Abstract available

  27. CASSIDY RJ, Patel PR, Zhang X, Press RH, et al
    Stereotactic Body Radiotherapy for Early-stage Non-small-cell Lung Cancer in Patients 80 Years and Older: A Multi-center Analysis.
    Clin Lung Cancer. 2017 Mar 16. pii: S1525-7304(17)30083.
    PubMed     Text format     Abstract available

  28. QIN A, Street L, Cease K, Viglianti BL, et al
    Clinical Determinants of Durable Clinical Benefit of Pembrolizumab in Veterans With Advanced Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2017 Feb 9. pii: S1525-7304(17)30041.
    PubMed     Text format     Abstract available


    Eur J Cardiothorac Surg

  29. SCHIRREN J, Schirren M, Lampl L, Sponholz S, et al
    Surgery for pulmonary metastases: quo vadis?
    Eur J Cardiothorac Surg. 2017;51:408-410.
    PubMed     Text format    


    Genes Chromosomes Cancer

  30. BI JH, Qiu ZW, Gazdar AF, Song K, et al
    Genome-wide copy number variation pattern analysis and a classification signature for non-small cell lung cancer.
    Genes Chromosomes Cancer. 2017 Apr 5. doi: 10.1002/gcc.22460.
    PubMed     Text format     Abstract available

  31. YOSHIMURA K, Inoue Y, Mori K, Iwashita Y, et al
    Distinct prognostic roles and heterogeneity of TTF1 copy number and TTF1 protein expression in non-small cell lung cancer.
    Genes Chromosomes Cancer. 2017 Apr 5. doi: 10.1002/gcc.22461.
    PubMed     Text format     Abstract available


    Int J Cancer

  32. CAROZZI FM, Bisanzi S, Carrozzi L, Falaschi F, et al
    Multimodal lung cancer screening using the ITALUNG Biomarker Panel and Low Dose Computed Tomography. Results of the ITALUNG biomarker study.
    Int J Cancer. 2017 Apr 7. doi: 10.1002/ijc.30727.
    PubMed     Text format     Abstract available

  33. HELLAND A, Brustugun OT, Nakken S, Halvorsen AR, et al
    High number of kinome-mutations in non-small cell lung cancer is associated with reduced immune response and poor relapse-free survival.
    Int J Cancer. 2017 Apr 7. doi: 10.1002/ijc.30726.
    PubMed     Text format     Abstract available

  34. LIN J, Gill A, Zahm SH, Carter CA, et al
    Metformin Use and Survival after Non-Small Cell Lung Cancer: A Cohort Study in the U.S. Military Health System.
    Int J Cancer. 2017 Apr 5. doi: 10.1002/ijc.30724.
    PubMed     Text format     Abstract available


    Int J Oncol

  35. ZENG Y, Zhu J, Shen D, Qin H, et al
    Repression of Smad4 by miR205 moderates TGF-beta-induced epithelial-mesenchymal transition in A549 cell lines.
    Int J Oncol. 2016;49:700-8.
    PubMed     Text format     Abstract available

  36. TANAKA T, Imamura T, Yoneda M, Irie A, et al
    Enhancement of active MMP release and invasive activity of lymph node metastatic tongue cancer cells by elevated signaling via the TNF-alpha-TNFR1-NF-kappaB pathway and a possible involvement of angiopoietin-like 4 in lung metastasis.
    Int J Oncol. 2016;49:1377-84.
    PubMed     Text format     Abstract available

  37. ZHONG N, Shi S, Wang H, Wu G, et al
    Silencing Aurora-A with siRNA inhibits cell proliferation in human lung adenocarcinoma cells.
    Int J Oncol. 2016;49:1028-38.
    PubMed     Text format     Abstract available

  38. KIM JS, Kang SJ, Jeong HY, Kim MW, et al
    Anti-EGFR immunonanoparticles containing IL12 and salmosin genes for targeted cancer gene therapy.
    Int J Oncol. 2016;49:1130-8.
    PubMed     Text format     Abstract available

  39. IM M, Kim A, Ma JY
    Ethanol extract of baked Gardeniae Fructus exhibits in vitro and in vivo anti-metastatic and anti-angiogenic activities in malignant cancer cells: Role of suppression of the NF-kappaB and HIF-1alpha pathways.
    Int J Oncol. 2016;49:2377-2386.
    PubMed     Text format     Abstract available

  40. LEE S, Matsuzaki H, Maeda M, Yamamoto S, et al
    Accelerated cell cycle progression of human regulatory T cell-like cell line caused by continuous exposure to asbestos fibers.
    Int J Oncol. 2017;50:66-74.
    PubMed     Text format     Abstract available

  41. NOGIMORI K, Hori T, Kawaguchi K, Fukui T, et al
    Increased expression levels of ppGalNAc-T13 in lung cancers: Significance in the prognostic diagnosis.
    Int J Oncol. 2016;49:1369-76.
    PubMed     Text format     Abstract available

  42. QIN S, Yang C, Zhang B, Li X, et al
    XIAP inhibits mature Smac-induced apoptosis by degrading it through ubiquitination in NSCLC.
    Int J Oncol. 2016;49:1289-96.
    PubMed     Text format     Abstract available


    J Cancer Res Clin Oncol

  43. TAO H, Tanaka T, Okabe K
    Doublecortin and CaM kinase-like-1 expression in pathological stage I non-small cell lung cancer.
    J Cancer Res Clin Oncol. 2017 Apr 5. doi: 10.1007/s00432-017-2405.
    PubMed     Text format     Abstract available


    J Clin Oncol

  44. ZHONG WZ, Liu SY, Wu YL
    Numbers or Stations: From Systematic Sampling to Individualized Lymph Node Dissection in Non-Small-Cell Lung Cancer.
    J Clin Oncol. 2017;35:1143-1145.
    PubMed     Text format    


    J Natl Cancer Inst


  45. Shared Gene Expression Alterations in Nasal and Bronchial Epithelium for Lung Cancer Detection.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format     Abstract available

  46. KAWAKAMI M, Mustachio LM, Rodriguez-Canales J, Mino B, et al
    Next-Generation CDK2/9 Inhibitors and Anaphase Catastrophe in Lung Cancer.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format     Abstract available

  47. LEE CK, Davies L, Wu YL, Mitsudomi T, et al
    Gefitinib or Erlotinib vs Chemotherapy for EGFR Mutation-Positive Lung Cancer: Individual Patient Data Meta-Analysis of Overall Survival.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format     Abstract available

  48. XU W, Neckers L
    Editorial: A USE1ful Biomarker and Molecular Target in Lung Cancer?
    J Natl Cancer Inst. 2017;109:1-3.
    PubMed     Text format    

  49. ROBLES AI, Harris CC
    Lung Cancer Field Cancerization: Implications for Screening by Low-Dose Computed Tomography.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format    


    Lancet Oncol

  50. GULLEY JL, Rajan A, Spigel DR, Iannotti N, et al
    Avelumab for patients with previously treated metastatic or recurrent non-small-cell lung cancer (JAVELIN Solid Tumor): dose-expansion cohort of a multicentre, open-label, phase 1b trial.
    Lancet Oncol. 2017 Mar 31. pii: S1470-2045(17)30240.
    PubMed     Text format     Abstract available


    Mol Cancer Ther

  51. SALGIA R
    MET in Lung Cancer: Biomarker Selection Based on Scientific Rationale.
    Mol Cancer Ther. 2017;16:555-565.
    PubMed     Text format     Abstract available


    Mol Carcinog

  52. CHAE DK, Ban E, Yoo YS, Kim EE, et al
    MIR-27a regulates the TGF-beta signaling pathway by targeting SMAD2 and SMAD4 in lung cancer.
    Mol Carcinog. 2017 Mar 31. doi: 10.1002/mc.22655.
    PubMed     Text format     Abstract available


    Oncogene

  53. SHAKYA R, Tarulli GA, Sheng L, Lokman NA, et al
    Mutant p53 upregulates alpha-1 antitrypsin expression and promotes invasion in lung cancer.
    Oncogene. 2017 Apr 3. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available

  54. OHM AM, Tan AC, Heasley LE, Reyland ME, et al
    Co-dependency of PKCdelta and K-Ras: inverse association with cytotoxic drug sensitivity in KRAS mutant lung cancer.
    Oncogene. 2017 Apr 3. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available

  55. JEN J, Lin LL, Lo FY, Chen HT, et al
    Oncoprotein ZNF322A transcriptionally deregulates alpha-adducin, cyclin D1 and p53 to promote tumor growth and metastasis in lung cancer.
    Oncogene. 2017 Apr 3. doi: 10.1038/onc.2017.
    PubMed     Text format    

  56. NOTO A, De Vitis C, Pisanu ME, Roscilli G, et al
    Stearoyl-CoA-desaturase 1 regulates lung cancer stemness via stabilization and nuclear localization of YAP/TAZ.
    Oncogene. 2017 Apr 3. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


    Oncol Rep

  57. KIM MH, Jeong YJ, Cho HJ, Hoe HS, et al
    Delphinidin inhibits angiogenesis through the suppression of HIF-1alpha and VEGF expression in A549 lung cancer cells.
    Oncol Rep. 2017;37:777-784.
    PubMed     Text format     Abstract available

  58. FUJIYOSHI K, Yamamoto G, Takahashi A, Arai Y, et al
    High concordance rate of KRAS/BRAF mutations and MSI-H between primary colorectal cancer and corresponding metastases.
    Oncol Rep. 2016 Dec 15. doi: 10.3892/or.2016.5323.
    PubMed     Text format     Abstract available


    PLoS Med

  59. TEN HAAF K, Jeon J, Tammemagi MC, Han SS, et al
    Risk prediction models for selection of lung cancer screening candidates: A retrospective validation study.
    PLoS Med. 2017;14:e1002277.
    PubMed     Text format     Abstract available


    PLoS One

  60. GOK DURNALI A, Paksoy Turkoz F, Ardic Yukruk F, Tokluoglu S, et al
    Outcomes of Adolescent and Adult Patients with Lung Metastatic Osteosarcoma and Comparison of Synchronous and Metachronous Lung Metastatic Groups.
    PLoS One. 2016;11:e0152621.
    PubMed     Text format     Abstract available

  61. OGUMA T, Nagaoka T, Kurahashi M, Kobayashi N, et al
    Clinical contributions of exhaled volatile organic compounds in the diagnosis of lung cancer.
    PLoS One. 2017;12:e0174802.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A


  62. Editorial Expression of Concern: WWOX gene restoration prevents lung cancer growth in vitro and in vivo.
    Proc Natl Acad Sci U S A. 2017 Apr 3. pii: 201704296.
    PubMed     Text format    


    Thorax

  63. PACI E, Puliti D, Lopes Pegna A, Carrozzi L, et al
    Mortality, survival and incidence rates in the ITALUNG randomised lung cancer screening trial.
    Thorax. 2017 Apr 4. pii: thoraxjnl-2016-209825.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: